Asunaprevir
≥98%
- Product Code: 77462
CAS:
630420-16-5
| Molecular Weight: | 398.45 g./mol | Molecular Formula: | C₃₅H₄₆ClN₅O₉S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD15145475 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Asunaprevir is primarily used in the treatment of chronic hepatitis C virus (HCV) infection. It is often administered in combination with other antiviral medications, such as daclatasvir, to enhance its efficacy. The drug works by inhibiting the NS3/4A protease, an enzyme essential for viral replication, thereby reducing the viral load in patients. This combination therapy is particularly effective for patients with HCV genotype 1b, offering a high rate of sustained virologic response (SVR). Asunaprevir is also considered a valuable option for patients who have previously failed other treatments or those who cannot tolerate interferon-based therapies. Its use has significantly improved outcomes for individuals with chronic HCV, contributing to better liver health and reducing the risk of complications such as cirrhosis and hepatocellular carcinoma.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿15,291.00 |
+
-
|
Asunaprevir
Asunaprevir is primarily used in the treatment of chronic hepatitis C virus (HCV) infection. It is often administered in combination with other antiviral medications, such as daclatasvir, to enhance its efficacy. The drug works by inhibiting the NS3/4A protease, an enzyme essential for viral replication, thereby reducing the viral load in patients. This combination therapy is particularly effective for patients with HCV genotype 1b, offering a high rate of sustained virologic response (SVR). Asunaprevir is also considered a valuable option for patients who have previously failed other treatments or those who cannot tolerate interferon-based therapies. Its use has significantly improved outcomes for individuals with chronic HCV, contributing to better liver health and reducing the risk of complications such as cirrhosis and hepatocellular carcinoma.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :